# miR-101-3p and Autotaxin in SLE Patients

> **NCT07252141** · — · NOT_YET_RECRUITING · sponsor: **Eman Mohamed Shawky** · enrollment: 40 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07252141
- **Lead sponsor:** Eman Mohamed Shawky
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07252141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07252141, "miR-101-3p and Autotaxin in SLE Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07252141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*